Medical Devices France

France Implantable Biosensors Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

France Implantable Biosensors Market Industry Trends and Forecast to 2034: Segmented by (Application, Duration, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

France · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $26.8 Mn Placeholder estimate
Estimate 2025 $29.7 Mn 2.4% of the global market
Projected 2034 $74.0 Mn 149.6% Adds $44.4 Mn over 9 forecast years
CAGR 2025–2034 10.7% Faster than 72% of 186 Medical Devices markets here
Key players 5
  • France is 2.36% of the global market.
  • In Europe, the largest is Germany at $44.4 Mn.
  • Fastest growing: Russia at 11.9% a year.
  • France ranks 3rd of 6 by size in Europe.

Market size projection

France

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$44.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Implantable Biosensors Market market size by year, France
YearMarket sizeChange that yearSince 2025
2024 (estimate) $26.8 Mn — —
2025 (base) $29.7 Mn +$2.9 Mn —
2026 (forecast) $32.8 Mn +$3.2 Mn +10.7%
2027 (forecast) $36.3 Mn +$3.5 Mn +22.5%
2028 (forecast) $40.2 Mn +$3.9 Mn +35.7%
2029 (forecast) $44.5 Mn +$4.3 Mn +50.2%
2030 (forecast) $49.3 Mn +$4.8 Mn +66.2%
2031 (forecast) $54.6 Mn +$5.3 Mn +84%
2032 (forecast) $60.4 Mn +$5.8 Mn +103.7%
2033 (forecast) $66.9 Mn +$6.5 Mn +125.5%
2034 (forecast) $74.0 Mn +$7.2 Mn +149.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

France Implantable Biosensors Market Analysis at a glance
Market size, 2025$29.7 Mn placeholder estimate
Forecast, 2034$74.0 Mn placeholder estimate
Growth (CAGR), 2025–203410.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, duration and end user (see all)
Key playersSenseonics, Medtronic, Abbott Laboratories, Endotronix, Profusa (see all)
Regulator in FranceANSMSource: ANSM, French medicines agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The France Implantable Biosensors Market Analysis Executive Summary

Implantable biosensors sit under the skin or inside the body and measure glucose, heart signals or pressure for months or years.

Key segments of the implantable Biosensors market include application (Glucose Monitoring, Cardiac Monitoring and Pressure Monitoring) and duration (Short-Term and Long-Term).

Bar chart: France Implantable Biosensors market size, 2024–2034, placeholder estimates. $26.8 Mn in 2024, $29.7 Mn in 2025 and $74.0 Mn in 2034, 10.7% CAGR.
France Implantable Biosensors market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

France Implantable Biosensors Market Dynamics

Market Growth Drivers

Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the implantable Biosensors market. Doctors are starting to use wearable data in care decisions.

Opportunity

Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the implantable Biosensors market strong growth.

Market Restraints

Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the implantable Biosensors market.

Competitive Landscape for Implantable Biosensors Market in France

The implantable Biosensors market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Implantable Biosensors Market in France

Implantable Biosensors in France: rules and payment

Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France.⁠[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.⁠[2]

[1] ANSM, French medicines agency. Checked 14 Nov 2026.

[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how implantable Biosensors products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in France.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Implantable Biosensors right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Implantable Biosensors in context

France compared

  • Health spending per person: 5,327 US$ per person (2024). World: 1,317 US$ per person (2023). 8th highest of the 13 countries we cover in Europe.[1]
  • Doctors: 3.28 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 12th highest of the 13 countries we cover in Europe.[2]
  • People aged 65 and over: 22.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 13 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Implantable Biosensors market in France?
Placeholder estimate: about $29.7 Mn in 2025, rising to about $74.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Implantable Biosensors market in France growing?
Placeholder estimate: about 10.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Implantable Biosensors market report cover?
The report splits the market by application (Glucose Monitoring, Cardiac Monitoring, Pressure Monitoring), duration (Short-Term, Long-Term) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Implantable Biosensors market?
Key players include Senseonics, Medtronic, Abbott Laboratories, Endotronix and Profusa.
What is driving the Implantable Biosensors market?
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the implantable Biosensors market. Doctors are starting to use wearable data in care decisions.
Who regulates Implantable Biosensors in France?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France. Source: ANSM, French medicines agency. Checked 14 Nov 2026.
How is healthcare paid for in France?
National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover. Source: Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
How much research is published on Implantable Biosensors?
PubMed lists 55 papers on Implantable Biosensors added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in France

See all

Related on remote monitoring and wearables

See the topic